Search Results
Graybug’s Goal: Extend Treatment to 6 Months or More
GrayBug -- Baltimore, MD
GrayBug - OIS@AAO 2015
Graybug Vision
FDA Approves New Treatment For Wet AMD
Graybug Could File GB-102 IND Next Year (OIS@ASRS 2016)
Graybug Moves Forward on GB-102 Ascending-Dose Trial
Graybug Vision Presentation on Retinal Drug Delivery Solutions at OIS@ASRS 2019
Treatment for age-related macular degeneration, presented by Heping Xu
"Macular Degeneration: Innovations and Insights" by Dr. Steven Bailey and Dr. Christina Flaxel
What is neovascular age-related macular degeneration and is it a chronic condition? | EYE NEWS TV
GenSight: Disruptive Gene Therapy in Retinal and Neurodegenerative Disease
